Active Not Recruiting NCT07077759
This study is looking at whether questionnaires and follow-up can help people with Postpartum Depression. Participants take part in the program and complete follow-up questionnaires or assessments.
In Hong Kong Depression, Anxiety Other Over 18 Years
Countries China
Sponsor Hong Kong Metropolitan University
Condition Depression, Anxiety Completed NCT06169709
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.
In The Hague ADHD Other Over 18 Years
Countries Netherlands
Sponsor Parnassia Groep
Condition ADHD Ongoing EUCTR 2022-001666-35
This study is ongoing in Bulgaria. It is testing KarXT for schizophrenia.
In Bulgaria Schizophrenia Other
Countries Bulgaria
Sponsor Karuna Therapeutics, Inc.
Condition Schizophrenia Completed NCT00473434
This study is completed. It focuses on schizophrenia.
Location not clearly listed Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries
Sponsor Janssen-Cilag Pty Ltd
Condition Schizophrenia Completed NCT00302380
This study is completed. It is testing Safety and Dopamine Transporter Binding Properties of C-11 Altropane for ADHD.
Location not clearly listed ADHD Other From 18 Months to 55 Years
Countries
Sponsor Massachusetts General Hospital
Condition ADHD Completed NCT01587118
This summary needs review. Please check the official study record and contact the research team for details.
In Tuscaloosa PTSD Behavioral From 19 Years to 65 Years
Countries United States
Sponsor Lori Davis, MD
Condition PTSD Terminated EUCTR 2008-000191-24
This summary needs review. Please check the official study record and contact the research team for details.
In Netherlands ADHD Other
Countries Netherlands
Sponsor Eli Lilly Nederland
Condition ADHD Terminated NCT05254405
This summary needs review. Please check the official study record and contact the research team for details.
In Austin PTSD Drug From 18 Years to 50 Years
Countries United States
Sponsor Donald Jeffrey Newport
Condition PTSD Completed NCT00814957
This study is completed in the United Kingdom. It is testing GSK618334 for Addiction.
In Harrow Addiction Drug From 30 Years to 55 Years
Countries United Kingdom
Sponsor GlaxoSmithKline
Condition Addiction Completed NCT01646827
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Cerritos Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Active Not Recruiting NCT04433858
This study is active but not recruiting in the United States. It is testing safety and Efficacy of Psilocybin for treatment-resistant depression.
Multiple locations, including Palo Alto Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Sheppard Pratt Health System
Condition Depression Completed NCT01666119
This study is completed in the United States. It is testing BEMA® Buprenorphine NX for Addiction.
Multiple locations, including Birmingham Addiction Drug From 18 Years to 65 Years
Countries United States
Sponsor BioDelivery Sciences International
Condition Addiction